Improving primary care prescribing safety using routine data for intervention and evaluation: four trials in 500+ practices

Similar documents
Optimising prescribing in primary care in the face of multimorbidity and polypharmacy

NSAIDs Change Package 2017/2018

TRIALS. Aileen Grant 1*, Tobias Dreischulte 2, Shaun Treweek 1 and Bruce Guthrie 1

Edinburgh Research Explorer

Tackling inappropriate polypharmacy in NHS Scotland

National Therapeutic Indicators and Additional Prescribing Measures 2017/18 - Early Release Document

Older People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG

The OPRAA Cohort. Emma Reynish

Can Audit and Feedback Reduce Antibiotic Prescribing in Dentistry?

Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

Polypharmacy: Guidance for Prescribing in Frail Adults

The Farr Institute Delivering new evidence and risk prediction tools through data analysis

Bulletin Independent prescribing information for NHS Wales

Using routinely collected clinical data to support Clinical Trials: a view from Scotland

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

The burden of psychotropic drug prescribing in people with dementia: a population database study

Cover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium

Carrying out a structured medication review

The epidemiology of polypharmacy

Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study

Polypharmacy Strategy for NHS Fife

The rising tide of polypharmacy and drug-drug interactions: population database analysis

Acknowledgements. The NTI Reference Group: Supported by:

MEDICINE OPTIMISATION IN BERKSHIRE EAST CCGS

Presentation outline

Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting

Medicines Optimisation Annual Report Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016

Summary of funded Dementia Research Projects

RAPiD: Reducing Antibiotic Prescribing in Dentistry

Impact and Predictors of Urinalysis Ordering Among General Medicine Patients

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Reshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

50 years of pharmacovigilance: unfinished job

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

Choosing Wisely Long Term Care Uniquely Canadian

Making Better Use of Registry Data in Designing Pragmatic Trials

Think Delirium. Dr Linda Wolff Scotland

Anticoagulatie en de oudere patiënt: Terughoudenheid gerechtvaardigd of niet?

Dementia Benchmarking Indicators Definitions and Data Sources Manual

How effective are national strategies for getting evidence into practice?

MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine

Detecting change in comparison to peers in NHS prescribing data: a novel application of cumulative sum methodology

Characteristics of selective and non-selective NSAID use in Scotland

The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias

K Barnett, 1 C McCowan, 1 J M M Evans, 2 N D Gillespie, 3 P G Davey, 1 T Fahey 1,4. Error management

NICE offer to STPs: CVD prevention

Ian Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital

Deprescribing: tackling increasing polypharmacy

David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

< = > less is more. De-diagnosing De-prescribing Non-testing

Le politerapie complesse: l'arte del deprescribing. Andrea Corsonello IRCCS INRCA - Cosenza

Safe Prescribing in Dementia

Deprescribing: reducing inappropriate polypharmacy

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Drug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome

SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)

Selecting the right patient for medication reviews

Polypharmacy in the Elderly

SMASH! The Salford Medication Safety Dashboard. Richard Williams. NIHR Greater Manchester Patient Safety Translational Research Centre

Physical comorbidity with bipolar disorder: lessons from UK data

Reduction of High Risk Medications Using A Quality Initiative Perspective

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Appendix 2017UEMS031

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Stronger together - optimizing pharmacotherapy on geriatric wards?

Deprescribing: A Practical Guide

Monitoring polypharmacy and reducing problematic prescribing

Polypharmacy and Deprescribing for Older People

A Year in Review: Novel Drug Approvals and Important FDA Safety Communications for the Year 2016

Primary Care Benchmarking Project. David Holland, Keele University

National Drug and Alcohol Treatment Waiting Times

Community Based Diabetes Prevention

The Urinary Tract Infection (UTI) Program for Long-Term Care

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial

The Opioid Crisis in Kentucky. Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare

Study period Total sample size (% women) 899 (37.7%) Warfarin Aspirin

An Audit and Feedback Intervention for Reducing Antibiotic Prescribing in General Dental Practice: The RAPiD Cluster Randomised Controlled Trial

Polypharmacy in the Elderly: Analysis of QRESEARCH Data

apability, pportunity and otivation

The SIMPATHY economic analysis tool

The aggressiveness of cancer care near the end of life: Is it a quality of care issue?

The aggressiveness of cancer care near the end of life: Is it a quality of care issue?

CARDIOVASCULAR RISK and NSAIDs

The first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit

Prescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May

NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56

A cluster RCT of enhanced pharmacy services (EPS) to improve outcomes for patients on methadone maintenance therapy (MMT)

Diagnosing Cancer in Grampian An Academic GP s Perspective

To Dip or Not To Dip. March Zoe Mason Care Home Pharmacist HCCG

Yellow Card Centre Scotland Centre for Adverse Reactions to Drugs (Scotland)

Medicines Optimisation the opportunities and challenges. Christina Short Medicines Optimisation Project Manager

World Leading Expertise in Use of Medical Records

Transcription:

University of Dundee School of Medicine Improving primary care prescribing safety using routine data for intervention and evaluation: four trials in 500+ practices

University of Dundee School of Medicine Improving primary care prescribing safety using routine data for intervention and evaluation: three trials and 1 interrupted time series study in 500+ practices

University of Dundee School of Medicine Preventable drug related harm Preventable drug-related morbidity (PRDM) is a concern o ~ 6.5% of all emergency hospital admissions are drug-related o ~ 2 to 4% are drug-related and preventable High-risk prescribing and monitoring cause 2/3 of PDRM o NSAIDs and antithrombotics: ~35% o Antihypertensives: ~30% o CNS active drugs: ~10% High-risk prescribing inappropriate or wrong prescribing o o Balance of benefit/risk Regular review necessary to ensure it continues to be appropriate

University of Dundee Odds ratio of patient receiving a high risk prescription in each practice School of Medicine 3.5 High-risk prescribing: Practice variation Odds ratio for each practice 3 Upper 95% CI 2.5 Lower 95% CI 2 1.5 1 0.5 0 Practices ranked in ascending order of prevalence of high risk prescribing

High risk prescribing and polypharmacy No. of chronic drugs 0 drugs 1-2 drugs 3-4 drugs 5-6 drugs 7-8 drugs 9-10 drugs 11+ drugs % getting a high risk prescription 4.3 11.0 12.7 14.5 18.3 21.5 26.6 Adjusted OR 1 2.7 3.2 3.8 5.0 6.1 7.9 Four fold variation between practices Guthrie B et al. BMJ 2011;342:d3514

Percentage of patients receiving specified number of drugs No. of drug classes dispensed in previous 84 days in 1995 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80+ 0 drugs 1 drug 2 drugs 3 drugs 4 drugs 5 drugs 6 drugs 7 drugs 8 drugs 9 drugs 10 drugs 11 drugs 12 drugs 13 drugs 14 drugs 15+ drugs Age group Guthrie B et al. BMC Medicine 2015

Percentage of patients receiving specified number of drugs Percentage of patients receiving specified number of drugs 100% No. of drug classes No. of drug dispensed classes dispensed in previous in last 84 84 days days in 1995 in 2010 100% 90% 90% 80% 80% 70% 70% 60% 60% 50% 50% 40% 40% 30% 30% 20% 20% 10% 10% 0% 0% 20-24 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80+ Age group Guthrie B et al. BMC Medicine 2015 0 drugs 1 drug 2 drugs 3 drugs 4 drugs 5 drugs 6 drugs 7 drugs 8 drugs 9 drugs 10 drugs 11 drugs 12 drugs 13 drugs 14 drugs 15+ drugs

Intervention design Which intervention components? Identify patients with high-risk prescribing from EMRs Review of patients identified Corrective action High-risk prescribing Emergency admissions

Intervention design Which intervention components? Behaviour change model (Michie et al)

Intervention design Which intervention components? Identify patients with high-risk prescribing from EMRs Review of patients identified Corrective action IT component Motivation Education High-risk prescribing Emergency admissions

EFIPPS

EFIPPS Study Design 262 practices from three Scottish health boards Study arm Randomised practices 1. Low intensity 88 practices 2. Higher intensity 87 practices 3. Highest intensity 87 practices

EFIPPS Intervention design Study arm 1. Low intensity 2. Higher intensity 3. Highest intensity Education Motivation IT Written education al material Written education al material Written education al material - Downloadable EMR searches to identify patients Feedback with benchmark Feedback with benchmark PLUS theory informed behaviour change intervention Downloadable EMR searches to identify patients Downloadable EMR searches to identify patients

EFIPPS findings

EFIPPS findings OR at 12 months Arm 2 vs Arm 1 0.88 (0.80 to 0.96) Arm 3 vs Arm 1 0.86 (0.78 to 0.95) Antipsychotics dementia 1.01/1.02 Triple whammy 0.91/0.91 NSAID aged 75+ 0.77/0.82 Antiplatelet + NSAID 0.88/0.82 OAC + NSAID 0.92/0.73 OAC + antiplatelet 0.82/0.72 Guthrie B et al BMJ 2016: i4079

DQIP

Study arm 1. Low intensity EFIPPS Intervention design Education Motivation IT - - - 2. Higher intensity Written educational material PLUS Educational Outreach Visit Financial incentives ( 350 participation fee plus 15 per review) IT tool - list of patients to review - facilitation of review - Run charts to monitor progress

DQIP Study Design 33 practices from one Scottish health board

DQIP findings

DQIP findings Primary outcome OR 0.63 (95% CI 0.57-0.68) Ongoing high-risk prescribing OR 0.60 (95% CI 0.53-0.67) New high-risk prescribing OR 0.77(95% CI 0.68-0.87) Sustained 12 months after the intervention stopped GI bleeding admissions OR 0.66 (95% CI 0.51-0.86) Heart failure admissions OR 0.73 (95% CI 0.56-0.95) Acute kidney injury admissions OR 0.84 (95% CI 0.68-1.09) Unrelated ACSA OR 1.02 (95% CI0.95-1.10) Dreischulte T et al. NEJM 2016; 374: 1053-1064

EPIPP design Cluster-randomised trial in 242 (100%) practices Both arms active Targets potentially problematic prescribing in asthma vs multiple urinary antibiotic prescribing Includes feedback of data for individual patients

EFIPPS Study Design 242 practices from one Scottish health board Study arm 1. Antibiotics for UTIs (control for arm 2) 2. Suboptimal prescribing for asthma (control for arm 1) Randomised practices 121 practices 121 practices

EPIPP Intervention design Study arm 1. Frequent use of antibiotics (control for arm 2) 2. Suboptimal asthma prescribing (control for arm 1) Education Motivation IT - - Practice level feedback - - Practice level feedback - Use of PIS to generate lists of individual patients for review - Use of PIS to generate lists of individual patients for review

POEMS design ITS in 54 (100%) practices Intervention is an informatics tool to support contractually incentivised polypharmacy review in people aged 75+ taking 10 or more drugs Operationalises 50+ pages of Scottish guidance 122 indicators of high-risk prescribing, potential overuse, potential underuse and monitoring failure Links data from primary care record, laboratories and unscheduled care (hospital, A&E/ER, GP out of hours)

Conclusion Prescribing safety is common and improvable Adds to evidence from previous trials PINCER (pharmacist led) OPTISCRIPT (GP led) All feasible in routine practice Many remaining questions Evidence is for selected indicators Apart from DQIP little data on sustainability Electronic vs paper

DQIP Aileen Grant, Adrian Hapca, Peter Donnan, Colin McCowan, Bruce Guthrie Health Informatics Centre EFIPPS Marion Bennie, Chris Robertson, Kim Kavanagh, Karen Barnett, Shaun Treweek, Lewis Ritchie, Dennis Petrie, Iain Bishop, Bruce Guthrie, ISD Scotland, edris EPIPP Sean Macbride-Stewart, Charis Marwick, Bruce Guthrie POEMS Jason Tang, Peter Donnan, Lyall Cameron, Graeme Longair, Neil Mellon, Grant McHattie, Bruce Guthrie

QUESTIONS?

DQIP References Dreischulte T et al. Safer prescribing: a trial of incentives, informatics and education. New England Journal of Medicine 2016:374 1053-1064 Guthrie B et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Medicine 2015;13:74 Grant A et al. Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ Open 2014;4:1 Guthrie B et al. High-risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross-sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514 EFIPPS Guthrie B et al. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ 2016; 354: i4079 Barnett KN et al. Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) a pragmatic three-arm-cluster randomised trial: designing the intervention. Implementation Science 2014:9(1);133